openPR Logo
Press release

Scabies Treatment Market Forecast and Segments, 2016-2026

07-26-2016 08:59 AM CET | Health & Medicine

Press release from: Future Market Insights

Scabies Treatment Market Forecast and Segments, 2016-2026

Scabies is an infectious skin disease caused by microscopic mites known as Sarcoptes scabiei, that lives inside human skin. The mites burrows into the skin and lay eggs after staying for two to three weeks. Scabies is an itchy, rash and pimple like skin disease condition found, globally. Scabies is a highly contagious disease and can pass through simple contact with affected person. The disease is pruritic in nature. The common sites for the rash are wrist elbow, armpit, waist, area between the fingers. Combination medicines are prescribed by physician are permethrin cream, benzyl benzoate lotion, crotamiton cream, sulfur ointment and one percent lindane lotion. In some caritical condition the patient has been prescribed with antihistamines, antibiotics and steroid creams. The more aggressive treatment in worst cases anthelmintic is given orally.

Scabies Treatment Market: Drivers & Restraints

According to the World Health Organization, there are 300 million cases of scabies globally every year. The market is driven in Pacific and Latin America due to high prevalence. Scabies market is expected to rise in countries having majority of young population like all the developing countries. The environmental factors are responsible for the scabies and will be driving the scabies treatment market during the forecast period. The homecare remedies can be a restraint as they will hinder the market of medications available on prescriptions.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1411

Scabies Treatment Market: Segmentation

Scabies Treatment is classified on the basis of drug administration type and disease type:

Based on medication type, the global Scabies Treatment is segmented into following:

Ointment

Gel

Creams

Lotions

Combinational medicines

Permethrin Cream

Benzyl Benzoate Lotion

Sulfur Ointment

Crotamiton Cream

Lindane Lotion

Other medicine

Ivermectin

Based on drug administration type, the Global Scabies Treatment is segmented into the following:

Oral

Topical

Scabies Treatment Market: Overview

Scabies Treatment Market is account to expand at promising CAGR during the forecast period due to its high prevalence rate across the globe. Extensive spreading of disease will also play an important role in expanding the market. Growth rate for scabies treatment will be rising substantially due to increase in investment on healthcare sector by the pharmaceutical companies which will mark the specificity of the disease and also help in increasing awareness level for scabies.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1411

Scabies Treatment Market: Region-wise Outlook

Geographically, scabies treatment market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, , Asia Pacific Excl Japan, Japan, and Middle East & Africa. North America accounts for high market share in scabies treatment market as approximately one million of affected including all age groups and sex and socio-economic status followed by Western and Eastern Europe including Middle east and Africa where the prevalence is greater than 10 per cent, although Asia Pacific and Latin America has comparatively more prevalent in children than from adults. Japan having less population with other hygienic facilities, the market here is here is stable. Overall the market share for scabies treatment will be rising as approximately 300 million people are reported with scabies around the world every year.

Scabies Treatment Market: Key Players

There are many key performers in Scabies Treatment market some of the names who are leading the market in Scabies Treatment worldwide are Renaissance Pharma Inc, Merck & Co., Ranbaxy Laboratories Inc., and others

Browse Full Report@ http://www.futuremarketinsights.com/reports/scabies-treatment-market

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Scabies Treatment Market Forecast and Segments, 2016-2026 here

News-ID: 351672 • Views:

More Releases from Future Market Insights

Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% CAGR and Rising Demand for Carotenoids and Omega Compounds
Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% …
The global eye health ingredients industry is projected to reach USD 360.3 million by 2035, expanding from USD 174.8 million in 2025 at a CAGR of 7.5%. Growth is fueled by increasing consumer awareness around preventive eye health, heavy screen exposure, and rising age-related vision issues. As consumers adopt nutraceuticals, fortified foods, and ocular supplements, demand for carotenoids, omega-based compounds, and botanical extracts continues to scale across retail and healthcare
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million by 2035
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million …
The global grapeseed oil market is projected to grow from USD 541.5 million in 2025 to USD 809.3 million by 2035, registering a CAGR of 4.1%. Rising demand across culinary, personal care, and nutraceutical applications is elevating its market value due to its rich antioxidant profile, vitamin E content, and plant-based origin. Health-conscious consumers are increasingly choosing grapeseed oil for premium cooking and natural skincare, while manufacturers expand cold-pressing capacities to
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by 7.8% CAGR
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by …
The global soybean enzymatic protein market is moving into a phase of rapid commercial adoption, projected to expand from USD 2.4 billion in 2025 to USD 5.2 billion by 2035, registering a CAGR of 7.8%. What began as a niche application segment during 2020-2024 has now matured into a scalable, mainstream protein category integrated into beverages, functional foods, meat alternatives, and nutritional supplements. Between 2025 and 2030, the market enters its
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growth
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growt …
The global squid market, valued at USD 12.7 billion in 2025, is projected to reach USD 18.4 billion by 2035, reflecting a 3.8% CAGR, driven by rising seafood demand, diversified product formats, and robust food supply chains. Steady consumption growth across Asia-Pacific, Europe, and North America continues to uplift commercial fishing, aquaculture, and value-added squid processing. Growth momentum between 2021 and 2025 shows a consistent upward curve, with the market expanding

All 5 Releases


More Releases for Scabies

Scabies Market Set to Witness Significant Growth by 2025-2034
Introduction Scabies is a highly contagious skin condition caused by the mite Sarcoptes scabiei, leading to intense itching, rashes, and secondary bacterial infections. It remains a significant public health issue worldwide, particularly in regions with crowded living conditions, limited access to healthcare, and inadequate sanitation. According to the WHO, scabies affects over 200 million people at any given time, underscoring its global health burden. The market for scabies treatment is expanding as
Scabies Treatment Market is Thriving Worldwide | Apotex, Mylan, Bayer
The Latest published market study on Global Scabies Treatment Market provides an overview of the current market dynamics in the Scabies Treatment, as well as what our survey respondents all outsourcing decision-makers predict the market will look like in 2032. The study breaks the market by revenue and volume (wherever applicable) and price history to estimate the size and trend analysis and identify gaps and opportunities. Some of the players
Scabies Treatment Market Top Emerging Trends, Growth And Business Opportunities …
Precision Business Insights published a research report on "Scabies Treatment Market By Drug type (Sulphur Ointment, Benzyl Benzoate Lotion, Lindane Lotion, Crotamiton Cream, Permethrin Cream, Others), route of administration (Oral, Topical), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027" Scabies is an infectious skin condition that causes itching and pimple-like rashes. The development of tiny mites called Sarcoptes scabiei in the skin causes this
Scabies Treatment Market Growing Worldwide with New Innovations; Industry Analys …
Scabies is an infectious skin disease caused by microscopic mites known as Sarcoptes scabiei, that lives inside human skin. The mites burrows into the skin and lay eggs after staying for two to three weeks. Scabies is an itchy, rash and pimple like skin disease condition found, globally. Scabies is a highly contagious disease and can pass through simple contact with affected person. The disease is pruritic in nature. The
Scabies Treatment Market to Observe Strong Development by 2026
Scabies is an infectious skin disease caused by microscopic mites known as Sarcoptes scabiei, that lives inside human skin. The mites burrows into the skin and lay eggs after staying for two to three weeks. Scabies is an itchy, rash and pimple like skin disease condition found, globally. Scabies is a highly contagious disease and can pass through simple contact with affected person. The disease is pruritic in nature. The
Scabies Treatment Market Dynamics, Segments and Supply Demand 2016-2026
Scabies is an infectious skin disease caused by microscopic mites known as Sarcoptes scabiei, that lives inside human skin. The mites burrows into the skin and lay eggs after staying for two to three weeks. Scabies is an itchy, rash and pimple like skin disease condition found, globally. Scabies is a highly contagious disease and can pass through simple contact with affected person. The disease is pruritic in nature. The